Cem Gorgun in

Cem Gorgun

Login to view DISC.
Director, Oncology Clinical Development at BioNTech SE
📍 Cambridge, Massachusetts, United States

Cem Gorgun is a physician-scientist and oncology development leader with over 15 years of experience in the biopharmaceutical industry. As a Director at BioNTech, he focuses on immuno-oncology, bispecifics, and first-in-human clinical programs. He completed his post-doctoral fellowship at Harvards T. H. Chan School of Public Health.

Outside of his direct professional responsibilities, he has contributed to philanthropic causes. He is listed as a donor to the Turkish Philanthropy Funds, an organization dedicated to creating lasting change by supporting communities in Turkey and the US.

He has recently co-authored multiple publications on investigational bispecific antibody immunotherapies, including Acasunlimab, for treating metastatic non-small cell lung cancer.

Read the full overview →
Experience
21 Years
Current Role
Director, Oncology Clinical Development
Job Level
Mid-senior
Location
Cambridge, Massachusetts, United States
Personality Overview

How Cem shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Cem cares about

Immuno-Oncology
A core area of his expertise, reflected in his current role at BioNTech and numerous recent publications on bispecific antibodies and immunotherapies.
Bispecific Antibodies
His work and publications, such as those on Acasunlimab and BNT314, show a deep focus on developing and testing bispecific antibody platforms for cancer treatment.
+5 more topics Login to view topics
Career

Work history

7-2023
Director, Oncology Clinical Development
BioNTech SE
7-2023
Global Clinical Lead
BioNTech SE
6-2021 - 7-2023
Medical Director, Oncology Clinical Science
Takeda Oncology
7-2020 - 6-2021
Scientific Director, Oncology Global Medical Affairs
Takeda Oncology
11-2017 - 7-2020
Assoc. Scientific Director Oncology Pipeline, Global Medical Affairs,
Takeda Oncology
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2000 - 2004
Post Doctoral Fellow
Harvard T.H. Chan School of Public Health
1993 - 1998
PhD Equil
Department of Medical Pharmacology, School of Medicine, Gazi University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other BioNTech SE Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Cem. Free, 10 seconds.